Newswise News from U.S. Army Medical Research Institute of Infectious Diseases display Latest news from U.S. Army Medical Research Institute of Infectious Diseases on Newswise en-us Copyright 2025 Newswise Newswise News from U.S. Army Medical Research Institute of Infectious Diseases 115 31 / /images/newswise-logo-rss.gif LifeArc Joins Transatlantic Collaboration to Develop a Treatment for Crimean-Congo Hemorrhagic Fever /articles/lifearc-joins-transatlantic-collaboration-to-develop-a-treatment-for-crimean-congo-hemorrhagic-fever/?sc=rsin /articles/lifearc-joins-transatlantic-collaboration-to-develop-a-treatment-for-crimean-congo-hemorrhagic-fever/?sc=rsin Wed, 23 Apr 2025 18:30:01 EST A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally. U.S. Army Medical Research Institute of Infectious Diseases Researchers' Study Show Advancements in GP38 Contributions to CCHFV and Monoclonal Antibody Therapies /articles/researchers-study-show-advancements-in-gp38-contributions-to-cchfv-and-monoclonal-antibody-therapies/?sc=rsin /articles/researchers-study-show-advancements-in-gp38-contributions-to-cchfv-and-monoclonal-antibody-therapies/?sc=rsin Tue, 08 Apr 2025 21:15:15 EST A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert Einstein College of Medicine and the University of California-Berkeley have advanced discoveries surrounding the viral glycoprotein GP38 expressed by the Crimean-Congo hemorrhagic fever virus (CCHFV). U.S. Army Medical Research Institute of Infectious Diseases Army and Illinois researchers design, test protein that may lead to COVID-19 therapeutic /articles/army-and-illinois-researchers-design-test-protein-that-may-lead-to-covid-19-therapeutic/?sc=rsin /articles/army-and-illinois-researchers-design-test-protein-that-may-lead-to-covid-19-therapeutic/?sc=rsin Mon, 17 Aug 2020 15:40:05 EST A novel receptor protein that binds to the SARS-CoV-2 virus and prevents it from entering cells may hold promise for treating COVID-19 and other coronavirus-related diseases, according to research published online Aug. 4 in the journal SCIENCE. U.S. Army Medical Research Institute of Infectious Diseases Ebola Virus Genome Provides Clues to Repeated Disease 'Flare-Ups' in Western Africa /articles/ebola-virus-genome-provides-clues-to-repeated-disease-flare-ups-in-western-africa/?sc=rsin /articles/ebola-virus-genome-provides-clues-to-repeated-disease-flare-ups-in-western-africa/?sc=rsin Fri, 29 Apr 2016 15:05:36 EST Ebola virus samples taken from patients in Liberia in June 2015 are strikingly similar in their genetic makeup to other Ebola virus sequences from Western Africa, according to research published online today in the journal Science Advances. The study sheds light on several aspects of the "flare-ups" that have occurred in Liberia since the country was initially declared free of Ebola virus disease. U.S. Army Medical Research Institute of Infectious Diseases